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Abstract
Objectives The creation of a new valid preclinical model of articular pain by the
intra-articular (i.a.) injection of mucilages for the screening of new treatments
against arthritis.
Methods A single intra-articular injection (20 ll) of mucilages (from Althaea
officinalis roots and Linum usitatissimun seeds) or vegetal components (Amor-
phophallus konjac gum powder and b-glucan, used as reference standard) were
assessed in the rat. The pathology progression was monitored by behavioural
measurements (paw pressure test, von Frey test, incapacitance test and beam bal-
ance test) and compared to that induced by the i.a. injections of monoiodioac-
etate (MIA) and Complete Freund’s Adjuvant (CFA), well-recognized models of
osteoarthritis and rheumatoid arthritis, respectively.
Key findings Among all, the mucilage of L. usitatissimun showed the best pro-
algic profile inducing a painful long-lasting condition. Hypersensitivity was char-
acterized as a mixed form of inflammatory and neuropathic pain by the respon-
siveness to ibuprofen (100 mg/kg, p.o.) and pregabalin (30 mg/kg, p.o.). The
histological evaluation of joint showed a damage that represents both MIA and
CFA features.
Conclusions In conclusion, a single i.a. injection of L. usitatissimun mucilage
can represent a valid model to assess articular pain in the rat for the screening of
new treatments against arthritis.
Introduction
Arthritic pain is common and is associated with worse
functional outcomes and poorer quality of life when com-
pared with a range of other chronic conditions.[1] A bewil-
dering array of guidelines and other evidence-based
resources are available, but the variability and the lack of
therapeutic responses can lead to frustration and disap-
pointment for both patients and health professionals.[2]
Although the therapeutic armamentarium has increased
considerably as a result of targeted modulation of factors
central to immunological regulation, around one-third of
patients respond insufficiently to any of the current treat-
ments.[3] The lack of effective treatments for arthritic pain
can be related also to the unsatisfactory available preclinical
models to test the validity of treatments. The heterogeneity
in clinical presentation requires animal models that can
reproduce the pathophysiology of the human pathological
condition for preclinical screening purposes.[4]
The aim of animal models that evoke arthritis is to
mimic in a controlled way the scale and progression of joint
damage. An ideal animal model is relatively inexpensive
and displays reproducible disease progression with a mag-
nitude of effect large enough to detect differences within a
short period of time. If the model progresses too rapidly to
end-stage degeneration, intermediate time points, which
are representative of osteoarthritis or rheumatoid arthritis
pathophysiology, may not be obtainable and in the absence
of this information, subtle effects of potential interventions
may be missed.[5] Another important aspect is the manage-
ability and the essential safety, for operators and for the
environment, of the substance used to induce the pathol-
ogy. Stemming from the existence of models using sub-
stances which are safe when ingested or used in the food
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and medical fields, but which cause inflammation if
injected, we identified a few such substances and assessed
their inflammatory potential upon intra-articular injection.
The aim of the present study was to assess a new animal
model of articular pain in the rat to be used in parallel with
the established model of osteoarthritis and of rheumatoid
arthritis induced by intra-articular (i.a.) injection of MIA
(monoiodoacetate) and CFA (Complete Freund’s Adju-
vant), respectively. The intra-articular injection allows to
reproduce a localized pain and not systemic which can thus
be compared to the human pathological condition. More-
over, this new model should share both inflammatory then
neuropathic features being fundamental for the screening
of new pharmacological treatments for the management of
articular pain states. Starting from the safety requirements
of the substance to be used, we looked for starting materials
similar to carrageenan, a polysaccharide of known safety in
food and medical settings,[6] high manageability, which
induces ‘foreign body’ reaction when injected.[7] Similarly,
safe polysaccharides are present in the mucilage of Althaea
officinalis and Linum usitatissimum, as well as in Amor-
phophallus konjac gum powder. b-glucan, having reported
action on the immune system activation was used as a ref-
erence polysaccharide. The hypersensitivity to mechanical
noxious and non-noxious stimuli as well as motor func-
tions were measured for 1 month. Histological evaluation
was performed on the compound that showed the best pro-
algic profile and compared histologically to MIA and CFA.
Materials and Methods
Plant materials
Althaea mucilage change in has been produced from Altaea
officinalis L. dried roots, cultivated and harvested in Italy by
Aboca SpA Societa Agricola. Linum mucilage change in has
been produced from Linum usatissimus L. seeds, cultivated
and harvested in Italy by Aboca SpA Societa Agricola.
Amorphophallus glucomannan gum powder (classification
according to commission regulation (EU) No 231/2012:
E425i) has been produced from Amorphophallus konjac
K. Koch fresh tuber, cultivated in Cina and supplied by Xi’an
Lanyor Biotech Co. Ltd, Shaanxi, China. (code KE90S).
Vegetal extracts production
The production process is characterized by extracting the
roots of A. officinalis and the seeds of Linum usitatissimun
with purified water (D/S 1:10). The production of A. konjac
is characterized by milling the tuber followed by ethanol
20–70% (v/v) extraction (D/S 1/20-26). More details in the
Supporting Information.
UHPLC-Q-ToF fingerprint method
Fingerprint analysis was performed by means of an UHPLC
(Agilent 1290 Infinity II) coupled with Dual AJS ESI source
Q-ToF (Agilent 6545). The UHPLC is equipped with a vac-
uum degasser, a binary pump, a Peltier thermostated
autosampler at 10 °C, a Peltier thermostated column com-
partment. More details are provided in the Supporting
Information.
Description of the instruments and of the
instrumental conditions
The analysis of saccharides was performed on a gas chro-
matograph instrument equipped with a capillary column
DB1 30 m, 0.25 mm, 0.25 lm (Agilent Technologies, Santa
Clara, CA, USA) and with a FID detector (Agilent Tech-
nologies). More details are provided in the Supporting
Information.
Determination of soluble and insoluble
dietary fibre, (according to AOAC 993.19 ed
17th 2003)
The soluble and insoluble dietary fibre was performed
according to AOAC 993.19 and AOAC 991.42, respectively.
More details are provided in the Supporting Information.
Determination of saccharides
The samples (0.5 g) were extracted by means of hot water
under stirring for 30 min. After filtration, the extract
(20 mg) was added to the internal standard (inositol for
monosaccharides, threalose for disaccharides) water was
removed under vacuum and the dry residue was derivatized
by means of trimethylsilylimidazole (100 ll) and analysed
by means of GC-FID. The calibration curve range was from
25 to 1000 mg/l for both the saccharides. The detection
limit was 0.1/100 g.
Determination of organic acids
The samples were extracted by means of water under stir-
ring for 30 min at room temperature. After filtration, the
extract was opportunely diluted and analysed by means of
HPLC-DAD. The calibration curve range was till 400 mg/l
for both the organic acid. The detection limit was 0.01 g/
100 g.
Preparation of the solution for test on
animals
The samples were prepared in a glass beaker using a
mechanical stirrer (RW 20.n; IKA Labortechnik, Milan,
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Italy). Each raw material was added slowly to the solvent, at
room temperature, to obtain a homogeneous solution. The
Althaea mucilage solution was prepared in saline solution at
the concentration of 40% (p/p). The Linum mucilage solu-
tion was prepared in PBS solution at the concentration
10% (p/p). The Amorphophallus glucomannan solution was
prepared in PBS solution at the concentration 1% (p/p).
Animals
For all the experiments described below, male Sprague Daw-
ley rats (Envigo, Varese, Italy) weighing approximately 200–
250 g at the beginning of the experimental procedure were
used. Formal approval to conduct the experiments described
was obtained from the Italian Ministry of Health (No. 54/
2014-B) and from the Animal Subjects Review Board of the
University of Florence. Experiments involving animals have
been reported according to ARRIVE guidelines.[8] More
details are provided in the Supporting Information.
Monoiodoacetate-induced osteoarthritis
Unilateral osteoarthritis was induced by injection of
monoiodoacetate (MIA; Sigma-Aldrich, Milan, Italy) into
the tibiotarsal joint.[9,10] More details are provided in the
Supporting Information.
Complete Freund’s Adjuvant-induced
inflammatory arthritis
Articular damage was induced by injection of CFA (Sigma-
Aldrich) into the tibiotarsal joint.[11,12] More details are
provided in the Supporting Information.
Compounds-induced articular damage
Articular damage was induced by a single injection of
Althea mucilage solution, Linum mucilage solution, Amor-
phophallus solution and b-glucan into the tibiotarsal joint.
More details are provided in the Supporting Information.
Drug treatment
For the acute treatments, ibuprofen (100 mg/kg) and pre-
gabalin (30 mg/kg) were suspended in 1% carboxymethyl-
cellulose sodium salt (CMC; Sigma-Aldrich) and per os
(p.o.) administered on days 3, 7, 14, 21, 28 from the intra-
articular injection of compounds. Behavioural measure-
ments were performed in time course every 15 min for 1 h.
In the graphs are reported only the measures performed at
30 min after drugs administration.
Paw pressure test
The nociceptive threshold in the rat was determined with
an analgesimeter (Ugo Basile, Varese, Italy) according to
the method described by Leighton et al.[13] More details
are provided in the Supporting Information.
von Frey test
The animals were placed in 20 9 20 cm plexiglass boxes
equipped with a metallic meshy floor, 20 cm above the
bench. A habituation of 15 min was allowed before the
test. An electronic von Frey hair unit (Ugo Basile) was
used: the withdrawal threshold was evaluated by apply-
ing force ranging from 0 to 50 g with a 0.2-g accura
cy.[14] More details are provided in the Supporting Info
rmation.
Incapacitance test
Weight-bearing changes were measured using an incapaci-
tance apparatus (Linton Instrumentation, Norfolk, UK) to
detect changes in postural equilibrium after a hind limb
injury.[15] More details are provided in the Supporting
Information.
Beam balance
A balance beam test consisted of the rats being placed on a
narrow strip of wood (30 9 1.3 cm) while balancing and
the scoring standards were as follows: 0 point, the four
limbs were all on the wood in a balance situations; 1 point,
limbs of one side were able to grasp the wood or shake on
the wood; 2 points, one or two limbs slipped from the
wood; 3 points, three limbs slipped from the wood; 4
points, suspended on the wood and fell over after strug-
gle.[16]
Rota rod test
Rota Rod apparatus (Ugo Basile) consisted of a base plat-
form and a rotating rod with a diameter of 6 cm and a
non-slippery surface. The rod was placed at a height of
25 cm from the base. The rod, 36 cm in length, was divided
into four equal sections by five disks. Thus, up to four rats
were tested simultaneously on the apparatus, with a rod-
rotating speed of 10 rpm. The integrity of motor coordina-
tion was assessed on the basis of the number of falls from
the rod for a maximum of 600 s. After a maximum of six
falls from the rod, the test was suspended and the time was
recorded.
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Histological evaluations
Histological evaluations were performed according to
Snekhalatha et al.[17] More details are provided in the Sup-
porting Information.
Statistical analysis
Each value represents the mean  SEM of ten rats per
group, performed in two different experimental sets.
Groups were as shown in the figures. Behavioural and his-
tological evaluations were performed by investigators who
were blinded to the experimental groups. The analysis of
variance was performed by ANOVA. A Bonferroni’s signifi-
cant difference procedure was used as post hoc comparison.
P values of less than 0.05 were considered significant. Data
were analysed using the ‘Origin8.1’ software.
Results
Extracts characterization
Althaea mucilage, Linum mucilage and Amorphophallus
glucomannan were characterized by means of UHPLC-q-
ToF acquiring the fingerprint of both negative and posi-
tive ions. As is possible to observe, negative ions are
more abundant than positive ones; Althaea mucilage
(Figure S1) and Linum mucilage (Figure S2) have more
metabolites contrariwise to that of Amorphophallus glu-
comannan (Figure S3). This behaviour can be explained
by the production process of the different matrices.
Amorphophallus glucomannan is a high purified mate-
rial responding to the regulatory specifications for food
additive E425i.
The study of the composition of Altheae mucilage,
Linum mucilage and Amorphophallus glucomannan is rep-
resented in Table 1. Compounds are rich in fibres, particu-
larly the soluble one, than contained saccharides (especially
sucrose) and organic acids as lactic acid and citric acid.
Altheae mucilage and Linum mucilage contained 14.4%
and 40.1% of fibres, 18.4% and 7.4% of saccharides and
3.8% and 6.8% of organic acids, respectively. Amorphophal-
lus glucomannan contained 88.7% of fibres but no saccha-
rides or organic acids (Table 1). Some small molecular
weight metabolites present in the fingerprints of each
matrices were identified and their concentration is reported
in Table S1. It is possible to observe that their concentra-
tion is very low, below 0.03%. The matrices are very com-
plex so actually is challenging the identification of all the
molecular species, also because most of the compounds of
our mucilage are polysaccharides, non-detectable by LC-
MS and traced by the soluble fibre test (results reported in
Table 1).
Behavioural measurements
All compounds (Altheae mucilage; Linum mucilage; Amor-
phophallus glucomannan; b-glucan; MIA and CFA) were
intra-articularly (i.a.) injected once on day 0. Behavioural
measurements were performed from day 0 (before i.a.
administrations) until day 28. In Figure 1a the response to
a noxious mechanical stimulus (paw pressure test) is
shown. MIA and CFA significantly lowered rats’ pain
threshold from day 2 until day 28 in comparison to the
control group (vehicle). Linum mucilage showed a similar
algic profile, reducing the weight tolerated on the posterior
paw for 28 days. In particular, the articular pain evoked by
the i.a. injection of Linum mucilage was significantly higher
with respect to MIA-treated rats on days 2, 4 and 22.
Althaea mucilage significantly reduced the pain threshold
from day 2 until day 14, then a recovery from articular
damage was observed. b-glucan injection evoked an inflam-
matory state of the joint that prevented the measure with
the paw pressure for the first week; starting from the second
week, the algic profile evoked was similar to that induced
by MIA injection. Amorphophallus glucomannan slightly
reduced the pain threshold of the animals without reaching
the statistical significance (Figure 1a). As measured by von
Frey apparatus, MIA and CFA lowered the pain withdrawal
threshold in response to a non-noxious mechanical stimu-
lus until day 28 after i.a. injection. MIA peaked in severity
on day 2 to progressively recover in the next days while
CFA showed a constant pain withdrawal threshold from
the day of injection until the end of the experiment (Fig-
ure 1b). Linum mucilage highlighted a similar allodynic
profile to CFA, reducing the paw withdrawal threshold of
the animals from day 2 to day 28. The articular pain evoked
by i.a. injection of b-glucan was measurable from day 7 and
remain statistically different from the control group until
day 28, reproducing an articular pain comparable to CFA.
Table 1 Composition’s study of vegetal extract used
Components
Compounds
Althaea
officinalis
roots mucil.
Linum
usitatissimum
seeds mucil.
Amorphophallus
konjac flour
Fibres, total 14.4 40.1 88.7
Soluble 13.8 36.8 79.8
Insoluble 0.6 3.3 8.9
Saccharides, total 18.4 7.4 0.0
Sucrose 15.9 2.0  0.1 0.0
Fructose 1.4 1.2 0.0
Glucose 1.0 0.0 0.0
Organic acids, total 3.8 6.8 0.0
Lactic acid 0.8 6.2 0.0
Citric acid 3.0 0.6 0.0
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Figure 1 Articular pain, behavioural measurement. (a) Effect of intra-articular injection of compounds in the rat, response to a noxious mechani-
cal stimulus (Paw pressure test); (b) effect of intra-articular injection of compounds in the rat, response to a non-noxious mechanical stimulus (von
Frey test); (c) effect of intra-articular injection of compounds in the rat, measure of postural imbalance related to pain (Incapacitance test); (d)
effect of intra-articular injection of compounds in the rat, measure of motor abilities related to pain (beam balance test); (e) effect of intra-articular
injection of compounds in the rat, measure of the joint diameter. Twenty microliters of Altheae mucilage, Linum mucilage, Amorphophallus gluco-
mannan and b-glucan were injected into the tibiotarsal joint of the rat on day 0. On the same day, two other groups of rats were intra-articularly
injected with monoiodioacetate (2 mg/25 ll) and Complete Freund’s Adjuvant (50 ll). Pain alterations were evaluated on days 0, 2, 3, 4, 7, 11,
14, 17, 21 and 28 after the intra-articular injection. Each value represents the mean of 10 rats per group performed in two different experimental
set. ^P < 0.05 and ^^P < 0.01 vs vehicle group; **P < 0.01 vs monoiodioacetate group.
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Articular pain evoked by Althaea mucilage peaked between
2 and 7 days after injection and was reduced during the
next days. Amorphophallus glucomannan slightly reduced
the pain threshold of the animals during the first 2 weeks
after injection in comparison to the others compounds
(Figure 1b). Similar results were obtained in the Incapaci-
tance test (Figure 1c). Both MIA and CFA increased the
postural unbalance of the animals in comparison to the
control group starting on day 2 until day 28 after treatment
although CFA is more harmful. The Δ weight between the
contralateral and the ipsilateral paw was also increased in
rats intra-articularly injected with Linum mucilage, Althaea
mucilage and b-glucan. The postural unbalance induced by
Linum mucilage is comparable to that evoked by CFA and
remained statistically significant in comparison to the con-
trol group till the end of the study (day 28). Althaea muci-
lage and b-glucan started to lose their effect in comparison
to CFA from the 3rd week after injection. Amorphophallus
glucomannan increased the postural unbalance from day 2
to day 28 without reach the values of MIA- and CFA-trea-
ted animals (Figure 1c). Linum mucilage, b-glucan and
CFA decreased the motor coordination and ability of the
rats from day 2 until the end of the experiments. Indeed,
the score assigned to these groups was statistically increased
with respect to the control animals. The effect evoked by
Amorphophallus glucomannan and Althaea mucilage was
statistically significant until day 21 to disappeared on day
28. The effect of MIA peaked on the 1st week then the ani-
mals started to regain their motor skills (Figure 1d). Simi-
lar results were obtained with the rota rod test and are
reported in Table S2. Moreover, we evaluated the swelling
of the ipsilateral paw measuring the joint diameter on days
0, 2, 7, 14, 21 and 28 after the injection of compounds (Fig-
ure 1e). CFA, Linum mucilage and b-glucan induced the
higher inflammatory effect with respect to the other com-
pounds that peaked during the 1st week after injection. The
following days, the swelling decreased and the joint diame-
ter returned to the value of control animals on day 21
except for the CFA-treated animals. Amorphophallus gluco-
mannan and Althaea mucilage increased the joint diameter
after their injection with a slight effect in comparison with
the other compounds. In particular, the increase was
induced by Amorphophallus glucomannan remained statis-
tically significant from day 2 to day 21 while Althaea muci-
lage showed a peak only on day 2. MIA slightly increased
the swelling of the paw reaching the statistical significance
on until day 7 (Figure 1e). To better characterize the type
of pain that the i.a. injection of compounds induced, we
acutely administered ibuprofen (100 mg/kg, per os) and
pregabalin (30 mg/kg, per os) to the animal treated with
MIA, CFA, Althaea mucilage, Linum mucilage and b-glu-
can (Figure 2). Ibuprofen and pregabalin are reference drug
currently used to counteract inflammatory and neuropathic
pain, respectively.[18,19] These treatments were acutely per-
formed on days 3, 7, 14, 21 and 28, and the analgesic effect
was measured by the paw pressure test (Figure 2 shows the
measure 30 min after administration). On MIA-treated rat,
ibuprofen and pregabalin were both active on days 3, 7 and
14 to reduce articular pain 30 min after treatment in com-
parison to the pretest (white column). On day 21, only pre-
gabalin was effective while on day 28 MIA-treated rats
spontaneously recovered from the pain state (Figure 2a).
On the contrary, on CFA-treated animals, only ibuprofen
was effective on days 21 and 28 while, during the previous
days, both the reference drugs were active (Figure 2b).
Ibuprofen counteracted Althaea mucilage-induced articular
pain on days 3 and 7 while on day 14 the effect decreased.
Pregabalin partially reduced the mechanical hyperagesia on
days 3, 7 and 14. No measurements were performed on
days 21 and 28 because the pro-algesic effect of Althaea
mucilage was almost vanished (Figure 2c). On day 3, 7 and
14, ibuprofen completely reversed the articular pain
induced by Linum mucilage reaching the values of control
animas at the paw pressure test. The analgesic efficacy
slightly decreased the next weeks. Pregabalin was partially
effective each time that was tested (Figure 2d). The articu-
lar swelling evoked by b-glucan prevented the measure with
the paw pressure for the first week and the effect of ibupro-
fen and pregabalin were tested from day 7 until day 28.
Both drugs increased the weight tolerated by the animals
on the ipsilateral paw without differences about their effi-
cacy. On day 28, pregabalin and ibuprofen were inactive
(Figure 2e). Amorphophallus glucomannan-injected ani-
mals were not treated with the reference drugs because their
capacity to induced articular damage was less effective.
Morphological analysis of the tibiotarsal
joint
The morphological analysis was performed on day 28
after treatment and only on Linum mucilage-treated ani-
mals because it shown the best algic profile. Intra-articu-
lar injection of Linum mucilage showed a typical profile
of rheumatoid arthritis characterized by hyperplastic syn-
ovium, that partially occupied the joint space, and by
the presence of an inflammatory infiltrate. At the same
time were presented several foci of articular cartilage
and bone erosions showing a profile compatible with a
joint affected by osteoarthritis. Joint space appears in
part ablated and in part replaced with hyperplastic sino-
vium (Figure 3). The histological analysis was made in
comparison with a model of rheumatoid arthritis (CFA)
and osteoarthritis (MIA). CFA was characterized by the
total ablation of the joint space that appears replaced by
hyperplastic tissue. Articular cartilage was completely
disappeared or present only in little foci even though
© 2019 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology, 71 (2019), pp. 971–981976
A new model of rat articular pain by mucilages Laura Micheli et al.
this tissue appears degenerated and damaged. The treat-
ment with MIA caused fibrin accumulation and the
presence of considerable articular cartilage and bone ero-
sions. Foci of bone erosion, as well as in Linum
mucilage, were not characterized by the presence of bone
proliferation areas indicating a repair strategy. In addi-
tion, even osteophytes were not visible. Moreover, the
intraarticular space markedly decreased in comparison
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with the control joint. Both CFA and MIA treatment
induced the presence of an abundant inflammatory infil-
trate (Table 2).
Discussion
The present study investigated the articular damage
induced by a singular i.a. injection of Altheae mucilage,
Linum mucilage, Amorphophallus glucomannan and the
polysaccharide b-glucan in comparison to that induced
by MIA and CFA. The purpose was to create a new ani-
mal model of articular pain to accompany those existing.
Assessment of pain in animal models of arthritis is pivo-
tal to the interpretation of a model’s utility in represent-
ing the clinical condition, and enabling accurate
translational medicine. Unfortunately, just as no animal
model perfectly mimics the complex processes involved
in the initiation and progression of articular pain as well
as arthritis-associated symptom in humans.[20] MIA and
CFA are two of the most animal model of articular dam-
age used to reproduced human osteoarthritis and
rheumatoid arthritis, respectively.[21–23] Intra-articular
injection of MIA, a chemical which inhibits glycolysis,
disrupts chondrocyte homeostatic balance and produces
cartilage degeneration and subsequent subchondral bone
loss.[22] The development of OA pathology and pain in
the MIA model typically occurs within 1–2 weeks and is
dose-dependent.[24,25] In addition to joint degeneration
and pain, the MIA model also generates acute and tran-
sient inflammation. Although the MIA model is ideal for
assessing OA pain and peripheral neuropathy, a limita-
tion of this model is that the structural histopathology of
the joint itself is severe and does not recapitulate all of
the physical features commonly associated with human
OA. Following intra-articular MIA injection, the joint
becomes hyperaemic, oedematous and there is an infiltra-
tion of circulating leucocytes.[15] By days 5–7 the inflam-
mation subsides and remains at low levels throughout the
subsequent development of MIA-induced OA.[15]
The heat killed mycobacterium arrangement of CFA is
similar to proteoglycan, and arthritis can be developed by a
cross-reactive CD4 T cell clone that recognizes an epitope
present on bacterial heat shock proteins and cartilage pro-
teoglycans.[26] In the CFA arthritis model, the animal devel-
ops chronic swelling and pain in and around the joints
with a release of proinflammatory cytokines from inflam-
matory cells, which causes the cartilage erosion and bone
destruction.[27] In order to induce articular damage to create
a new model of pain, we used compounds that are able to
mimic an inflammatory state resembling human articular
pain when i.a. injected, although they are safe when given
orally.
(a) (b)
(c) (d)
Figure 3 Histology of tibiotarsal joints. Representative micrographs of tibiotarsal joint from the four experimental groups. (a) Control animal. (b)
Animal treated with Complete Freund’s Adjuvant; dashed line indicates the hypothetical localization of joint space; asterisk indicates the fibrous
tissue replacing the joint space. (c) Animal treated with monoiodioacetate; black arrows indicates bone erosions; arrow head indicate fibrin deposi-
tion in joint space. (d) Animal treated with Linum mucilage; black arrow indicate the fusion of tibia and tarsus. Asterisk indicates the fibrous tissue
that infiltrates the joint space. Calibration bar 100 lm.
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Of all compounds tested, Linum mucilage showed the
best algic profile with several similarities to CFA model.
The articular pain peaked during the first week after the
mucilage injection matching with the maximum swelling of
the paw. However, the algic conditions remained stable
until the end of the experiment. To strength the idea that
saccharides are responsible of the articular damage, we
reported the effect of b-glucan, a polysaccharide, in com-
parison to the effect of Amorphophallus glucomannan that
did not contain saccharides. Amorphophallus glucomannan
slightly reduced the pain threshold of the animals while b-
glucan is more painful. On the other hand, the mucilage
Althaea mucilage that contains the 15.90% of saccharides
with respect to the 6.23% of Linummucilage lost its efficacy
after the 2nd week. These evidences suggested that the noci-
ceptive action is due not only to saccharides but required
the action of other components. In particular, Linum muci-
lage, previously mentioned as the most harmful, contained
the 6.23% of lactic acid with respect to 0.76% of Althaea
mucilage, and the acidosis of the articular joint space can
exacerbate the damage induced by saccharides. As reported
by literature, rheumatoid arthritis is also known as a pro-
gressive acidic illness as acids build-up in the connective
and fatty tissues that lead to joint destruction and func-
tional disability if the patient has an acidic lifestyle and
diet.[28,29] Moreover, in some people with rheumatoid
arthritis, the retention of dietary, metabolic, respiratory
and/or environmental acids leads to chronic inflammation
and destruction of the cartilage, bone, and ligaments, caus-
ing deformity of the joints.[28,29]
In order to determine if the articular pain induced by
these compounds shares more similarities with neuropathic
or inflammatory pain, we evaluated the efficacy of antinoci-
ceptive drugs specifically used for these type of pain. If MIA
and CFA models acquire, respectively, a neuropathic and
inflammatory characteristic with the progression of the
pathology, Althaea mucilage and b-glucan were sensible to
both pregabalin and ibuprofen, the reference drugs used for
the treatment of neuropathic and inflammatory pain,
respectively, indicating a type of multifactorial pain. Also,
Linum mucilage responded to both drugs but, as CFA, only
ibuprofen was active on day 28. The result indicated a
greater preponderance of the inflammatory state with
respect to the neuropathic.
The histological analysis highlighted that in animals
treated with Linum mucilage, the tibiotarsal joint showed
intermediate characteristics between the two reference
models. These morphological evaluations suggested that
this model represents a complex pathology with a dual nat-
ure: one characterized by a joint damage from an anoma-
lous load as in human osteoarthritis and the other based
on an immune-inflammatory reaction such as in rheuma-
toid arthritis. Thus, mucilage appeared able to induce pain
with both neuropathic and inflammatory bases. We are
among the first to describe a bridge model between two
clinically well distinct pathologies and this kind of model
offers the possibility of studying mechanisms involved in
the genesis of both inflammatory and immune-mediated
pathologies. Moreover, our model may give the possibility
to early screening the efficacy of novel compounds on a
single set of animals representing a double-faced pathologi-
cal tool.
Conclusion
Safe compounds for ingestion can mimic an inflammatory
state when intra-articularly injected, possible due to their
complexity of chemical and physical–chemical characteris-
tics. Linum mucilage showed best results. This mucilage-
induced articular damage shows common features with the
osteoarthritis and rheumatoid arthritis evoked by MIA and
CFA, respectively. The saccharides and the lactic acid pre-
sent in the mucilage are the most responsible for the joint
damage, and an accurate characterization of the extract is
necessary for the reproducibility of the date in order to use
Linum mucilage as a new animal model for articular pain.
The creation of this new hybrid and valid preclinical model
of articular pain can be useful for the screening of new
pharmacological treatments for the management of articu-
lar pain states.
Table 2 Morphological analysis of the tibiotarsal joints
Morphological
parameters
Groups
Score: from 0 (absent) to 3 (severe)
Vehicle MIA CFA
Linum
usitatissimum
mucil.
Inflammatory
infiltrate
0  0 1.3  0.3 1.7  0.3 1.3  0.3
Synovial
hyperplasia
0  0 1.7  0.3 2.0  0.1 1.6  0.
Fibrin
deposition
0  0 2.0  0.3 3.0  0.1 1.8  0.4
Synovial
vascularity
0  0 1.7  0.3 1.6  0.2 1.5  0.5
Cartilage erosion 0  0 1.3  0.3 2.0  0.1 1.7  0.3
Bone erosion 0  0 1.0  0.1 1.2  0.1 1.2  0.3
Joint space 0  0 1.7  0.4 3.0  0.1 1.7  0.2
Histological evaluation of the tibiotarsal joints. Rats were intra-
articularly injected with Linum usitatissimum mucilage (20 ll), MIA
(2 mg/25 ll) and CFA (50 ll) on day 0. On day 28, animals were
sacrificed and the tibiotarsal joints were collected for the histological
evaluations. Sections were observed and an histological score (0: absent;
1: mild; 2: moderate; 3: severe) was attributed to the following morpho-
logical parameters: (1) inflammatory infiltrate; (2) synovial hyperplasia;
(3) fibrin deposition; (4) synovial vascularity; (5) cartilage erosion; (6)
bone erosion; (7) joint space. Each value represents the mean  SEM of
10 rats per group performed in two different experimental set.
© 2019 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology, 71 (2019), pp. 971–981 979
Laura Micheli et al. A new model of rat articular pain by mucilages
Declarations
Conflict of interest
All Authors declare no conflict of interest.
Funding
This research was founded by the Italian Ministry of
Instruction, University and Research (FIRB grant to CT)
and by the University of Florence (FAR grant to CG).
Acknowledgements
This research was funded by the Italian Ministry of Instruc-
tion, University and Research (MIUR) and by the Univer-
sity of Florence. The authors’ contributions are as follows:
L. Di Cesare Mannelli and C. Ghelardini designed the
research, L. Micheli performed the experiments and wrote
the manuscript, E. Trallori and C. Parisio performed the
behavioural experiments, L. Cinci and E. Lucarini per-
formed the histological experiments. All authors read and
approved the final manuscript.
References
1. Sprangers MA et al. (2000) Which
chronic conditions are associated with
better or poorer quality of life? J Clin
Epidemiol 2000; 53: 895–907.
2. Hing E et al. National ambulatory
medical care survey: 2004 summary.
Adv Data 2006; 374: 1–33.
3. Burmester GR, Pope JE. Novel treat-
ment strategies in rheumatoid arthri-
tis. Lancet 2017; 389: 2338–2348.
4. Dinser R. Animal models for arthritis.
Best Pract Res Clin Rheumatol 2008;
22: 253–267.
5. Teeple E et al. Animal models of
osteoarthritis: challenges of model
selection and analysis. AAPS J 2013;
15: 438–446.
6. Younes M et al. Re-evaluation of car-
rageenan (E 407) and processed Euch
euma seaweed (E 407a) as food addi-
tives. EFSA J 2018; 16: 5238.
7. Fehrenbacher JC et al. Models of
inflammation: carrageenan- or Com-
plete Freund’s Adjuvant (CFA)-
induced edema and hypersensitivity in
the rat. Curr Protoc Pharmacol 2012;
5: 541–544.
8. McGrath JC, Lilley E. Implementing
guidelines on reporting research
using animals (ARRIVE etc.): new
requirements for publication in BJP.
Br J Pharmacol 2015; 172: 3189–
3193.
9. Di Cesare Mannelli L et al. Low dose
native type II collagen prevents pain
in a rat osteoarthritis model. BMC
Musculoskelet Disord 2013; 14: 228.
10. Maresca M et al. Pain relieving and
protective effects of Astragalus
hydroalcoholic extract in rat arthritis
models. J Pharm Pharmacol 2017; 69:
1858–1870.
11. Butler SH et al. A limited arthritic
model for chronic pain studies in the
rat. Pain 1992; 48: 73–81.
12. Maresca M et al. Acute effect of Cap-
paris spinosa root extracts on rat artic-
ular pain. J Ethnopharmacol 2016; 193:
456–465.
13. Leighton G et al. Kappa-Opioid ago-
nists produce antinociception after i.v.
and i.c.v. but not intrathecal adminis-
tration in the rat. Br J Pharmacol
1988; 93: 553–560.
14. Sakurai M et al. Oxaliplatin-induced
neuropathy in the rat: involvement of
oxalate in cold hyperalgesia but not
mechanical allodynia. Pain 2009; 147:
165–174.
15. Bove SE et al. Weight bearing as a
measure of disease progression and
efficacy of antiinflammatory com-
pounds in a model of monosodium
iodoacetate induced osteoarthritis.
Osteoarthr Cartilage 2003; 11: 821–
830.
16. Ding Y et al. Motor balance and coor-
dination training enhances functional
outcome in rat with transient middle
cerebral artery occlusion. Neuroscience
2004; 123: 667–674.
17. Snekhalatha U et al. Evaluation of
complete Freund’s adjuvant-induced
arthritis in a Wistar rat model. Com-
parison of thermography and
histopathology. Z Rheumatol 2013; 72:
375–382.
18. Pan T et al. Anti-rheumatoid arthritis
effects of traditional Chinese herb
couple in adjuvant-induced arthritis
in rats. J Ethnopharmacol 2017; 205:
1–7.
19. Sofat N et al. The effect of pregabalin
or duloxetine on arthritis pain: a clin-
ical and mechanistic study in people
with hand osteoarthritis. J Pain Res
2017; 10: 2437–2449.
20. Piel MJ et al. Pain assessment in ani-
mal models of osteoarthritis. Gene
2014; 537: 184–188.
21. Billiau A, Matthys P. Modes of action
of Freund’s adjuvants in experimental
models of autoimmune diseases. J
Leuko Biol 2001; 70: 849–860.
22. Combe R et al. The monosodium
iodoacetate model of osteoarthritis: a
model of chronic nociceptive pain in
rats? Neurosci Lett 2004; 370: 236–
240.
23. Guzman et al. Monoiodoacetate-
induced histologic changes in sub-
chondral bone and articular cartilage
of rat femorotibial joints: an animal
model of osteoarthritis. Toxicol Pathol
2003; 31: 619–624.
24. Janusz MJ et al. Moderation of
iodoacetate-induced experimental
osteoarthritis in rats by matrix metal-
loproteinase inhibitors. Osteoarthr
Cartilage 2001; 9: 751–760.
25. Prakken BJ et al. Heat shock protein
60 and adjuvant arthritis: a model for
T cell regulation in human arthritis.
Springer Semin Immunopathol 2003; 25:
47–63.
26. Singh S et al. Chemical and pharma-
cological studies on fixed oil of Oci-
mum sanctum. Indian J Exp Biol 1996;
34: 1212–1215.
27. Schuelert N, McDougall JJ. Grading of
monosodium iodoacetate-induced
© 2019 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology, 71 (2019), pp. 971–981980
A new model of rat articular pain by mucilages Laura Micheli et al.
osteoarthritis reveals a concentration-
dependent sensitization of nociceptors
in the knee joint of the rat. Neurosci
Lett 2009; 465: 184–188.
28. Young RO, Young SR. Sick and Tired.
New York, NY: Woodland Publishing
Inc Salt Lake City, 2001.
29. Young RO, Young SR. The pH Miracle
Revised and Updated. New York, NY:
Grand Central Life & Style Hachett
Book Group, 2012.
Supporting Information
Additional Supporting Information
may be found in the online version of
this article:
Appendix S1. Supplementary mate-
rials and Figures.
Figure S1. UHPLC-q-ToF finger-
prints of Althaea mucilage.
Figure S2. UHPLC-q-ToF finger-
prints of Linum mucilage.
Figure S3. UHPLC-q-ToF finger-
prints of Amorphophallus glucoman-
nan gum powder (classification
according to commission regulation
(EU) No 231/2012: E425i).
Table S1. Some metabolites identi-
fied in Althaea mucilage, Linum
mucilage and Amorphophallus gluco-
mannan.
Table S2. Rota rod test.
© 2019 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology, 71 (2019), pp. 971–981 981
Laura Micheli et al. A new model of rat articular pain by mucilages
